Home506197 • BOM
add
Bliss GVS Pharma Ltd
Nakaraang pagsara
₹159.20
Sakop ng araw
₹158.10 - ₹164.50
Sakop ng taon
₹92.25 - ₹184.95
Market cap
17.06B INR
Average na Volume
100.88K
P/E ratio
27.25
Dividend yield
0.31%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.18B | 2.74% |
Gastos sa pagpapatakbo | 682.58M | 6.38% |
Net na kita | 242.60M | -42.66% |
Net profit margin | 11.14 | -44.22% |
Kita sa bawat share | — | — |
EBITDA | 414.11M | -23.69% |
Aktuwal na % ng binabayarang buwis | 28.04% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.20B | 34.93% |
Kabuuang asset | 12.83B | 7.13% |
Kabuuang sagutin | 2.34B | 0.06% |
Kabuuang equity | 10.48B | — |
Natitirang share | 105.02M | — |
Presyo para makapag-book | 1.66 | — |
Return on assets | — | — |
Return on capital | 7.68% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 242.60M | -42.66% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Itinatag
1984
Website
Mga Empleyado
831
